The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Abstract
Acrp30 is a circulating protein synthesized in adipose tissue. A single injection in mice of purified recombinant Acrp30 leads to a 2-3-fold elevation in circulating Acrp30 levels, which triggers a transient decrease in basal glucose levels. Similar treatment in ob/ob, NOD (non-obese diabetic) or streptozotocin-treated mice transiently abolishes hyperglycemia. This effect on glucose is not associated with an increase in insulin levels. Moreover, in isolated hepatocytes, Acrp30 increases the ability of sub-physiological levels of insulin to suppress glucose production. We thus propose that Acrp30 is a potent insulin enhancer linking adipose tissue and whole-body glucose metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adiponectin administration decreases IHTG (35), increases hepatic insulin sensitivity (36), and reverses obesity-related skeletal muscle insulin resistance (37).”
From Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity (2009) · cites this paper as [36]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,407
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Self-citationPlasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,261
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2005 · Cited by 2,007
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,021
Humanin: A Novel Central Regulator of Peripheral Insulin Action
Muzumdar, R. H., Huffman, D. M., Atzmon, G., Buettner, C., Cobb, L. J., Fishman, S., Budagov, T., Cui, L., Einstein, F. H., Poduval, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006334 · Cited by 254
Shklyaev, S., Aslanidi, G., Tennant, M., Prima, V., Kohlbrenner, E., Kroutov, V., Campbell‐Thompson, M., Crawford, J. M., Shek, E. W., Scarpace, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2333912100 · Cited by 249
Adiponectin: a versatile player of innate immunity
Luo, Y., & Liu, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw012 · Cited by 253
Adiponectin and its role in the obesity-induced insulin resistance and related complications.
Haluzı́k, M., Pařízková, J., & Haluzík, M. (2004) · Physiological Research · doi:10.33549/physiolres.930479 · Cited by 247
Adipocyte-Derived Hormones, Cytokines, and Mediators
Rondinone, C. M. (2006) · Endocrine · doi:10.1385/endo:29:1:81 · Cited by 252
Discrimination Between Obesity and Insulin Resistance in the Relationship With Adiponectin
Abbasi, F., Chu, J. W., Lamendola, C. A., McLaughlin, T., Hayden, J. M., Reaven, G. M., & Reaven, P. D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.585 · Cited by 246
Daniele, G., Guardado‐Mendoza, R., Winnier, D. A., Fiorentino, T. V., Zuo, P., Cornell, J. E., Andreozzi, F., Jenkinson, C. P., Cersósimo, E., Federici, M., et al. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0543-1 · Cited by 252
Adiponectin and atherosclerotic disease
Shimada, K., Miyazaki, T., & Daida, H. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.020 · Cited by 244
Adiponectin: Systemic contributor to insulin sensitivity
Pajvani, U. B., & Scherer, P. E. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0065-2 · Cited by 251
Self-citationSopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P., & Smith, U. (2004) · Obesity Research · doi:10.1038/oby.2004.51 · Cited by 255
Induction of Adiponectin in Skeletal Muscle by Inflammatory Cytokines: in Vivo and in Vitro Studies
Delaigle, A. M., Jonas, J.-C., Bauche, I. B., Cornu, O., & Brichard, S. M. (2004) · Endocrinology · doi:10.1210/en.2004-0503 · Cited by 241
Kanazawa, I., Yamaguchi, T., Yamauchi, M., Yamamoto, M., Kurioka, S., Yano, S., & Sugimoto, T. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1184-7 · Cited by 239
Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease?
Fisman, E. Z., & Tenenbaum, A. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-103 · Cited by 245
Adipose Tissue and Adipokines—Energy Regulation from the Human Perspective
Trayhurn, P., Bing, C., & Wood, I. S. (2006) · Journal of Nutrition · doi:10.1093/jn/136.7.1935s · Cited by 243
Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
Parida, S., Siddharth, S., & Sharma, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102519 · Cited by 248
Andréelli, F., Foretz, M., Knauf, C., Cani, P. D., Perrin, C., Iglesias, M. A., Pillot, B., Bado, A., Tronche, F., Mithieux, G., et al. (2006) · Endocrinology · doi:10.1210/en.2005-0898 · Cited by 244
Schulze, M. B., Rimm, E. B., Shai, I., Rifai, N., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1680 · Cited by 235
Paniagua, J. A., de la Sacristana, A. G., Romero, I., Vidal‐Puig, A., Latre, J. M., Sánchez, E., Pérez‐Martínez, P., López‐Miranda, J., & Pérez‐Jiménez, F. (2007) · Diabetes Care · doi:10.2337/dc06-2220 · Cited by 242
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
Defronzo, R. A. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00389.x · Cited by 236
LIAO, Y., TAKASHIMA, S., MAEDA, N., OUCHI, N., KOMAMURA, K., SHIMOMURA, I., HORI, M., MATSUZAWA, Y., FUNAHASHI, T., & KITAKAZE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.018 · Cited by 236
LeRoith, D. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01276-7 · Cited by 245
Neschen, S., Morino, K., Dong, J., Wang-Fischer, Y., Cline, G. W., Romanelli, A. J., Rossbacher, J. C., Moore, I. K., Regittnig, W., Muñoz, D. S., et al. (2007) · Diabetes · doi:10.2337/db06-1206 · Cited by 236
Vitaglione, P., Morisco, F., Mazzone, G., Amoruso, D. C., Ribecco, M. T. S., Romano, A., Fogliano, V., Caporaso, N., & D’Argenio, G. (2010) · Hepatology · doi:10.1002/hep.23902 · Cited by 231
Côté, M., Mauriège, P., Bergeron, J., Alméras, N., Tremblay, A., Lemieux, I., & Després, J.-P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1711 · Cited by 230
Regulation of Pituitary Cell Function by Adiponectin
Rodríguez‐Pacheco, F., Martínez‐Fuentes, A. J., Tovar, S. A., Pinilla, L., Tena‐Sempere, M., Diéguez, C., Castano, J. P., & Malagón, M. M. (2006) · Endocrinology · doi:10.1210/en.2006-1019 · Cited by 231
Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies
Giorgino, F., Laviola, L., & Eriksson, J. W. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01385.x · Cited by 230
The Metabolic Syndrome and Inflammation
Sutherland, J. P., McKinley, B., & Eckel, R. H. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.82 · Cited by 243
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
Phillips, S. A., Ciaraldi, T. P., Kong, A. P. S., Bandukwala, R., Aroda, V. R., Carter, L., Baxi, S. C., Mudaliar, S. R. D., & Henry, R. R. (2003) · Diabetes · doi:10.2337/diabetes.52.3.667 · Cited by 228
Increased CD36 protein as a response to defective insulin signaling in macrophages
Liang, C.-P., Han, S., Okamoto, H., Carnemolla, R., Tabas, I. A., Accili, D., & Tall, A. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19528 · Cited by 233
Purmorphamine Induces Osteogenesis by Activation of the Hedgehog Signaling Pathway
Wu, X., Walker, J. R., Zhang, J., Ding, S., & Schultz, P. G. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.06.010 · Cited by 224
Mantzoros, C. S., Li, T., Manson, J. E., Meigs, J. B., & Hu, F. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0372 · Cited by 224
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum
Kusminski, C. M., McTernan, P. G., Schraw, T., Kos, K., O’Hare, J. P., Ahima, R. S., Kumar, S., & Scherer, P. E. (2007) · Diabetologia · doi:10.1007/s00125-006-0577-9 · Cited by 225
Self-citationWilliams, M. A., Qiu, C., Muy-Rivera, M., Vadachkoria, S., Song, T., & Luthy, D. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031201 · Cited by 220
Gerich, J. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.4.447 · Cited by 222
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Frystyk, J., Tarnow, L., Hansen, T. K., Parving, H.-H., & Flyvbjerg, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1850-z · Cited by 223
Chung, S. J., Nagaraju, G. P., Nagalingam, A., Muniraj, N., Kuppusamy, P., Walker, A., Woo, J., Győrffy, B., Gabrielson, E., Saxena, N. K., et al. (2017) · Autophagy · doi:10.1080/15548627.2017.1332565 · Cited by 224
Jeremic, N., Chaturvedi, P., & Tyagi, S. C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25450 · Cited by 211
Hoffstedt, J., Nordström, E. A., Sjölin, E., Wåhlén, K., & Arner, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031458 · Cited by 220
Plasma Adiponectin Levels in Overweight and Obese Asians
Yang, W., Lee, W., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C., Chen, C., Tai, T., & Chuang, L. (2002) · Obesity Research · doi:10.1038/oby.2002.150 · Cited by 221
The role of oxidative stress in the development of obesity and obesity-related metabolic disorders
Čolak, E., & Pap, D. (2020) · Journal of Medical Biochemistry · doi:10.5937/jomb0-24652 · Cited by 243
Angiopoietin-related growth factor antagonizes obesity and insulin resistance
Oike, Y., Akao, M., Yasunaga, K., Yamauchi, T., Morisada, T., Ito, Y., Urano, T., Kimura, Y., Kubota, Y., Maekawa, H., et al. (2005) · Nature Medicine · doi:10.1038/nm1214 · Cited by 200
Heidemann, C., Hoffmann, K., Spranger, J., Klipstein‐Grobusch, K., Möhlig, M., Pfeiffer, A. F. H., & Boeing, H. (2005) · Diabetologia · doi:10.1007/s00125-005-1743-1 · Cited by 225
Endocannabinoids in the regulation of appetite and body weight
Kirkham, T. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00004 · Cited by 224
Addy, C., Gavrila, A., Tsiodras, S., Brodovicz, K. G., Karchmer, A. W., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020795 · Cited by 218
Plasma Adiponectin Complexes Have Distinct Biochemical Characteristics
Schraw, T., Wang, Z. V., Halberg, N., Hawkins, M. A., & Scherer, P. E. (2008) · Endocrinology · doi:10.1210/en.2007-1561 · Cited by 226
Self-citationCelis, J. E., Moreira, J. M. A., Cabezón, T., Gromov, P., Friis, E., Rank, F. E., & Gromova, I. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500030-mcp200 · Cited by 222
Crystal structures of the human adiponectin receptors
Tanabe, H., Fujii, Y., Okada‐Iwabu, M., Iwabu, M., Nakamura, Y., Hosaka, T., Motoyama, K., Ikeda, M., Wakiyama, M., Terada, T., et al. (2015) · Nature · doi:10.1038/nature14301 · Cited by 220
Trayhurn, P., Drevon, C. A., & Eckel, J. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2010.535835 · Cited by 214
Adiponectin Represses Colon Cancer Cell Proliferation via AdipoR1- and -R2-Mediated AMPK Activation
Kim, A. Y., Lee, Y. S., Kim, K. H., Lee, J. H., Lee, H. K., Jang, S. H., Kim, S., Lee, G. Y., Lee, J.-W., Jung, S.-A., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0498 · Cited by 214
Structural insights into adiponectin receptors suggest ceramidase activity
Vasiliauskaité-Brooks, I., Sounier, R., Rochaix, P., Bellot, G., Fortier, M., Hoh, F., Colibus, L. D., Bechara, C., Saied, E. M., Arenz, C., et al. (2017) · Nature · doi:10.1038/nature21714 · Cited by 216
Adipogenesis and fat-cell function in obesity and diabetes
Camp, H. S., Ren, D., & Leff, T. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02396-1 · Cited by 212
Ghai, R., Waters, P. J., Roumenina, L. T., Gadjeva, M. G., Kojouharova, M. S., Reid, K. B. M., Sim, R. B., & Kishore, U. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.11.001 · Cited by 212
Nishimura, M., Izumiya, Y., Higuchi, A., Shibata, R., Qiu, J., Kudo, C., Shin, H. K., Moskowitz, M. A., & Ouchi, N. (2007) · Circulation · doi:10.1161/circulationaha.107.725044 · Cited by 207
Adipokines, diabetes and atherosclerosis: an inflammatory association
Freitas‐Lima, L. C., Braga, V. A., de França-Silva, M. D. S., Cruz, J. C., Santos, S. H. S., Monteiro, M. M. D. O., & Balarini, C. M. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00304 · Cited by 218
Adipose tissue: an endocrine organ playing a role in metabolic regulation
Booth, A. D., Magnuson, A. M., Fouts, J. K., & Foster, M. T. (2016) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0073 · Cited by 220
Globular adiponectin upregulates nitric oxide production in vascular endothelial cells
Hattori, Y., Suzuki, M., Hattori, S., & Kasai, K. (2003) · Diabetologia · doi:10.1007/s00125-003-1224-3 · Cited by 210
Heid, I. M., Wagner, S. A., Gohlke, H., Iglseder, B., Mueller, J. C., Cip, P., Ladurner, G., Reiter, R., Stadlmayr, A., Mackēvičs, V., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-0747 · Cited by 209
Park, J., Rho, H. K., Kim, K. H., Choe, S. S., Lee, Y. S., & Kim, J. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.12.5146-5157.2005 · Cited by 212
Ueki, K., Fruman, D. A., Yballe, C. M., Faßhauer, M., Klein, J. C., Asano, T., Cantley, L. C., & Kahn, C. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305602200 · Cited by 209
RetractedYamamoto, Y., Hirose, H., Saito, I., Nishikai, K., & Saruta, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031163 · Cited by 210
FOXO-binding partners: it takes two to tango
van der Vos, K. E., & Coffer, P. J. (2008) · Oncogene · doi:10.1038/onc.2008.22 · Cited by 212
Metabolic Effects of Rosiglitazone in HIV Lipodystrophy
Hadigan, C. M., Yawetz, S., Thomas, A., Havers, F. P., Sax, P. E., & Grinspoon, S. K. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-10-200405180-00008 · Cited by 207
Immunological functions of leptin and adiponectin
Carbone, F., Rocca, C. L., & Matarese, G. (2012) · Biochimie · doi:10.1016/j.biochi.2012.05.018 · Cited by 213
Differential Role of Leptin and Adiponectin in Cardiovascular System
Ghantous, C. M., Azrak, Z., Hanache, S., Abou-Kheir, W. G., & Zeidan, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/534320 · Cited by 211
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
Pajvani, U. B., Shawber, C. J., Samuel, V. T., Birkenfeld, A. L., Shulman, G. I., Kitajewski, J., & Accili, D. (2011) · Nature Medicine · doi:10.1038/nm.2378 · Cited by 193
The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile
Poirier, B., Bidouard, J., Cadrouvele, C., Marniquet, X., Staels, B., O'Connor, S. E., Janiak, P., & Herbert, J. M. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00374.x · Cited by 206
Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease
Ohashi, K., Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Nagaretani, H., Kumada, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.049 · Cited by 203
Adiponectin in Human Cord Blood: Relation to Fetal Birth Weight and Gender
Sivan, E., Mazaki‐Tovi, S., Pariente, C., Efraty, Y., Schiff, E., Hemi, R., & Kanety, H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031174 · Cited by 202
Frystyk, J., Berne, C., Berglund, L., Jensevik, K., Flyvbjerg, A., & Zethelius, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1067 · Cited by 201
Adipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 234
Guerre-Millo, M. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2007.08.002 · Cited by 203
Fat Deposition and Fat Effects on Meat Quality—A Review
Schumacher, M. L., DelCurto-Wyffels, H. M., Thomson, J. M., & Boles, J. A. (2022) · Animals · doi:10.3390/ani12121550 · Cited by 220
Resistin and Adiponectin Expression in Visceral Fat of Obese Rats: Effect of Weight Loss
Milan, G., Granzotto, M., Scarda, A., Calcagno, A., Pagano, C., Federspil, G., & Vettor, R. (2002) · Obesity Research · doi:10.1038/oby.2002.149 · Cited by 199
Oberbach, A., Tönjes, A., Klöting, N., Faßhauer, M., Kratzsch, J., Busse, M. W., Paschke, R., Stümvoll, M., & Blüher, M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02127 · Cited by 199
Endocrinology of Adipose Tissue - An Update
Fischer‐Posovszky, P., Wabitsch, M., & Hochberg, Z. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-976539 · Cited by 202
Adiponectin as a growth inhibitor in prostate cancer cells
Bub, J. D., Miyazaki, T., & Iwamoto, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.103 · Cited by 200
Systemic Fate of the Adipocyte-Derived Factor Adiponectin
Halberg, N., Schraw, T., Wang, Z. V., Kim, J., Yi, J., Hamilton, M. P., Luby‐Phelps, K., & Scherer, P. E. (2009) · Diabetes · doi:10.2337/db08-1750 · Cited by 207
Self-citationPaniagua, J. A. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i19.483 · Cited by 197
Adiponectin: Anti-inflammatory and cardioprotective effects
Villarreal-Molina, M. T., & Antuna-Puente, B. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.030 · Cited by 206
Kim, S. P., Ellmerer, M., Citters, G. W. V., & Bergman, R. N. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2453 · Cited by 195
Matsuda, M., & Shimomura, I. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9271-7 · Cited by 205
Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation
Wang, C., Pattabiraman, N., Zhou, J., Fu, M., Sakamaki, T., Albanese, C., Li, Z., Wu, K., Hulit, J., Neumeister, P., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6159-6173.2003 · Cited by 195
Self-citationPathogenesis and pathophysiology of the cardiometabolic syndrome
Kirk, E. P., & Klein, S. (2009) · The Journal of Clinical Hypertension · doi:10.1111/j.1559-4572.2009.00054.x · Cited by 195
Molecular Mechanism of Insulin Resistance and Obesity
Kadowaki, T., Hara, K., Yamauchi, T., Terauchi, Y., Tobe, K., & Nagai, R. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322801003 · Cited by 198
Basu, R., Pajvani, U. B., Rizza, R. A., & Scherer, P. E. (2007) · Diabetes · doi:10.2337/db07-0185 · Cited by 198
Self-citationExercise Induced Adipokine Changes and the Metabolic Syndrome
Golbidi, S., & Laher, I. (2014) · Journal of Diabetes Research · doi:10.1155/2014/726861 · Cited by 202
Pathogenesis of Non-alcoholic Steatohepatitis: Human Data
Edmison, J. M., & McCullough, A. J. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.02.011 · Cited by 195
Fumeron, F., Aubert, R., Siddiq, A., Betoulle, D., Péan, F., Hadjadj, S., Tichet, J., Wilpart, E., Chesnier, M., Balkau, B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1150 · Cited by 193
Hypoxia and Adipocyte Physiology: Implications for Adipose Tissue Dysfunction in Obesity
Trayhurn, P. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161156 · Cited by 194
FAT CELLS: Afferent and Efferent Messages Define New Approaches to Treat Obesity
Lafontan, M. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095843 · Cited by 191
Nilsson, L., Binart, N., Bohlooly-Y, M., Bramnert, M., Egecioglu, E., Kindblom, J., Kelly, P. A., Kopchick, J. J., Ormandy, C. J., Ling, C., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.026 · Cited by 191
Richards, A. A., Stephens, T., Charlton, H. K., Jones, A., Macdonald, G. A., Prins, J. B., & Whitehead, J. P. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0390 · Cited by 196
Adipocyte CREB Promotes Insulin Resistance in Obesity
Qi, L., Saberi, M., Zmuda, E. J., Wang, Y., Altarejos, J. Y., Zhang, X., Dentin, R., Hedrick, S., Bandyopadhyay, G. K., Hai, T., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.006 · Cited by 196
Parlati, L., Régnier, M., Guillou, H., & Postic, C. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100346 · Cited by 201
Kopp, H., Krzyżanowska, K., Möhlig, M., Spranger, J., Pfeiffer, A. F. H., & Schernthaner, G.-H. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802983 · Cited by 190
Obesity and asthma: A coincidence or a causal relationship? A systematic review
Ali, Z., & Ulrik, C. S. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.03.019 · Cited by 197
Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice
Lee, Y., Cha, B., Saito, K., Yamakawa, H., Choi, S., Yamaguchi, K., Yonezawa, T., Teruya, T., Nagai, K., & Woo, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.034 · Cited by 189
Perseghin, G., Lattuada, G., Danna, M., Sereni, L. P., Maffi, P., COBELLI, F. D., Battezzati, A., Secchi, A., Maschio, A. D., & Luzi, L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00279.2003 · Cited by 187
Obesity: Current and potential pharmacotherapeutics and targets
Narayanaswami, V., & Dwoskin, L. P. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.015 · Cited by 188
Chabrolle, C., Tosca, L., & Dupont, J. (2007) · Reproduction · doi:10.1530/rep-06-0244 · Cited by 191
Metadata
- Authors
- Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Scherer, Philipp E.
- Venue
- Nature Medicine
- Published
- 2001-08
- Volume
- 7
- Issue
- 8
- Pages
- 947-953
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1524321743
- Cited by
- 2,526
- References
- 33
- Citations by year
- 2026: 12 · 2025: 23 · 2024: 38 · 2023: 44 · 2022: 51 · 2021: 54 · 2020: 67 · 2019: 72 · 2018: 62 · 2017: 81 · 2016: 79 · 2015: 84 · 2014: 106 · 2013: 129 · 2012: 133
- FWCI
- 104.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (T32GM007491)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK 07513-15, R01DK055758, T32DK007513)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- adiponectin, hepatic insulin action, insulin sensitivity, glucose production, hyperglycemia, ob/ob mice, streptozotocin-induced diabetes, adipose tissue, adipokines, glucose metabolism
- MeSH terms
- Animals, Blood Proteins, Energy Intake, Cell Line, Glucose, Humans, Hypoglycemic Agents, Insulin, Liver, Mice, Inbred C57BL, Proteins, Recombinant Proteins, Thiazoles, Adipocytes, Intercellular Signaling Peptides and Proteins, Thiazolidinediones, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review